2024 ASCO Direct™ Hawaii
Learn How to Claim Your Credit
Click here to view on-demand content!
Total Health's 2024 ASCO Direct™ Hawaii Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference with on-demand access for registered attendees.
Accreditation Information | 9.50
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 9.50 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 9.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 9.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Learner Notification
Objectives - After Attending This Program You Should Be Able To
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.
Stimulate innovative strategies for new and additional research related to treatment and prevention.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name
Commercial Interest:Relationship
Jared Acoba GSK:Research Grant Overall Principal Investigator
Pedro Barata Merck, Eisai, EMD Serono, Pfizer, Caris Life Sciences, AstraZeneca, Exelixis, Bayer:Consultant UroToday, Targeted Oncology :Scientific/Medical Advisory Board Member
Jeffrey Berenberg NA
Craig Boddy NA
manojkumar bupathi NA
John Chan Astra Zeneca, Eisai, Genmab, GSK, Immunogen, Myriad, Seagen, AbVvie, Pfizer:Speakers Bureau Daiichi Sankyo, Karyopharm , Roche :Consultant Mille Das Verily, Varian, United Therapeutics, Celgene, Abbvie, Novartis, Merck, Genetech, CellSight:Research Grant Site Principal Investigator Genentech (uncompensated), Eurofins:Consultant Catalyst, Astra Zeneca, Sanofi/Genzyme, Regeneron, Janssen, Beigene, Guardant, Gilead, Bristol Myer Squibb, Novocure:Scientific/Medical Advisory Board Member
Beth DuPree Perimeter Medical:Consultant Medtronic, Prelude Dx :Speakers Bureau Caliber Medical, Gateway Sciences, Innerstill Health :Other
Laura Huppert Pfizer, AstraZeneca:Scientific/Medical Advisory Board Member
Reshma Mahtani Agendia, Amgen, Astra Zeneca, Daiichi, Eisai, Gilead, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma, Sanofi, SeaGen, Sermonix, Stemline:Consultant Astra Zeneca, Genenetch, Veru:Research Grant Overall Principal Investigator Agendia, Astra Zeneca, Amgen, Daiichi Sankyo, Eisai, Gilead, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer:Consultant
Shane Morita NA
Elizabeth S. Nakasone NA
Neal Palafox NA
Stephanie Si Lim NA Naoto Ueno Gilead Sciences,, Daiichi Sankyo, Inc., AstraZeneca Pharmaceuticals, Sysmex, Preferred Medicine, Carisma Therapeutics, Inc., Bayer Corporation, OncoCyte, Medica Scientia Innovation Research, S.L. (MEDSIR), Peptilogics, Pfizer Inc., Takeda Pharmaceuticals (Japan):Consultant
Victoria M. Villaflor Sanofi, AstraZeneca, Novocure, Bristol Myers Squibb, Regeneron:Consultant Johnson & Johnson:Private Stock Shareholder TGen:Research Grant Overall Principal Investigator Gilead, AstraZeneca, Novocure, Bristol Myers Squibb, Regeneron, Daiichi Sankyo:Consultant TGen:Research Grant Overall Principal Investigator
Karen Winkfield Sanofi, Bristol Myers Squibb, Bayer Healthcare, Reinsurance Group of America, Merck, NantHealth, ROSE, Astellas Pharma Inc:Consultant
Evan Wu NA
Teruo Yamauchi NA
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
For CE/CME click on the “Claim CME” button below.
For ABIM MOC click on the “Claim MOC” button below
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate or need help, go to help.cmecertificateonline.com